...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation
Dryness & GSM faq

Do you offer remote check-ins or in-person only?

Do you offer remote check-ins or in-person only? We provide both. Many follow-ups for genitourinary syndrome of menopause (GSM) work well by phone or video, especially when reviewing moisturiser schedules, lubricant choices, or local vaginal oestrogen/DHEA technique. We’ll recommend in-person review for red flags, uncertain diagnoses, or when a pelvic/vulval exam, device-based session, or injectables are planned. Educational only. Results vary. Not a cure.

Clinical Context

Who is a good fit for remote check-ins? People whose main limiter is vestibular sting and dryness and who are trialling foundations: scheduled moisturiser 2–4 nights weekly; generous, compatible lubricant at every higher-friction moment; accurate placement of local oestrogen/DHEA when acceptable. Many reach comfort with coaching and small tweaks, without needing an immediate examination.

Who should prioritise in-person? Anyone with red flags (malodorous discharge, fever, visible haematuria, or new post-menopausal bleeding), persistent ulcers/changing plaques, or deep pelvic pain; those starting device-based or injectable adjuncts; and people recovering from pelvic/perineal surgery who need clearance and a tailored plan.

Alternatives and next steps. If hormones are unsuitable or declined, remote reviews can still optimise non-hormonal care: moisturiser routine, low-irritant products, lubricant base (water-based vs silicone-based), pelvic health physiotherapy referrals for muscle guarding, and dilator pacing. Educational only. Results vary. Not a cure.

Evidence-Based Approaches

NHS care formats: The NHS explains that GP and specialist consultations may run by phone/video or face to face; remote appointments are used for follow-up and medication reviews when safe and appropriate (NHS appointments overview).

Guideline framing for GSM: The NICE Menopause Guideline (NG23) recommends offering information on vaginal moisturisers and lubricants and considering low-dose local vaginal oestrogen when symptoms affect quality of life; these steps are well suited to remote coaching and review.

Prescribing and product detail: UK dosing/cautions for vaginal oestrogens and prasterone (DHEA) are set out in the British National Formulary (BNF), supporting technique optimisation and safety checks, often achievable via teleconsultation.

Effectiveness benchmarks: Systematic reviews in the Cochrane Library show that local vaginal oestrogens improve dryness, soreness, dyspareunia and vaginal pH versus placebo—useful context for remote goal-setting and timelines.

Pathophysiology & differential diagnosis: Peer-reviewed overviews on PubMed describe GSM biology (thinner epithelium, raised pH, fewer Lactobacillus) and help decide when an examination is required versus when remote optimisation is appropriate.